Education And Data Will Be Key To Byooviz Uptake
Real-World Evidence Is Expected To Help Build Confidence In US Lucentis Biosimilar
Education for healthcare professionals and real-world evidence will be important factors in building trust in Byooviz, Samsung Bioepis and Biogen have told Generics Bulletin, acknowledging it will “take some time” for ophthalmologists to grow more comfortable prescribing biosimilars.
